Myelodysplastic syndrome: Classification and prognostic systems

Oncology Reviews

Volumn 4, Issue 1, 2010, Pages 25-33

  Invernizzi, Rosangela ^a,b   Filocco, Agnese ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Classification; Diagnosis; Myelodysplastic syndrome; Prognosis

Indexed keywords

ARSENIC; CYANOCOBALAMIN; CYTOTOXIC AGENT; FOLIC ACID; LEAD;

ACUTE GRANULOCYTIC LEUKEMIA; ALCOHOL CONSUMPTION; ANEMIA; APLASTIC ANEMIA; BLOOD; BLOOD SMEAR; BONE MARROW; BONE MARROW BIOPSY; CELL STRUCTURE; CHROMOSOME ABERRATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CYANOCOBALAMIN DEFICIENCY; CYTOGENETICS; CYTOPENIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; DYSERYTHROPOIESIS; ERYTHROID CELL; FOLIC ACID DEFICIENCY; GRANULOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFLAMMATION; IRRADIATION; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; MEGAKARYOCYTE; MYELOBLAST; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NEOPLASM; OVERALL SURVIVAL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 77249138148     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-009-0033-4     Document Type: Review

References (63)

1. R Invernizzi 2002 The role of apoptosis in myelodysplastic syndrome Haematologica 87 337 339 11940474
2. M Cazzola L Malcovati 2005 Myelodysplastic syndrome-coping with ineffective hematopoiesis N Engl J Med 352 536 538 10.1056/NEJMp048266 1:CAS:528:DC%2BD2MXhtFemsr0%3D 15703418 (Pubitemid 40204666)
3. R Invernizzi E Travaglino 2008 Increased apoptosis as a mechanism of ineffective erythropoiesis in myelodysplastic syndromes Clin Leuk 2 113 120 10.3816/CLK.2008.n.014 1:CAS:528:DC%2BD1cXntlSjtbw%3D
4. JM Bennett D Catovsky MT Daniel G Flandrin DA Galton HR Gralnick, et al. 1982 Proposals for the classification of the myelodysplastic syndrome Br J Haematol 51 89 99 10.1111/j.1365-2141.1982.tb07293.x
5. G Tricot R Vlietinck MA Boogaerts B Hendrickx C De Wolf-Peeters H Van den Berghe RL Verwilghen 1985 Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis Br J Haematol 60 19 32 10.1111/j.1365-2141.1985.tb07381.x 1:STN:280:DyaL2M3is1agsA%3D%3D 3859319
6. RH Jacobs MA Cornbleet JW Vardiman RA Larson MM LeBeau JD Rowley 1986 Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes Blood 67 1765 1772 1:STN:280:DyaL283hs1Knuw%3D%3D 3708160
7. Third MIC Cooperative Study Group 1988 Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders Cancer Genet Cytogenet 32 1 10 10.1016/0165-4608(88)90303-2 (Pubitemid 18116194)
8. GE Verhoef S Pittaluga C De Wolf-Peeters, et al. 1995 FAB classification of myelodysplastic syndromes: merits and controversies Ann Hematol 71 3 11 10.1007/BF01696227 1:STN:280:DyaK2MzlvFaqsQ%3D%3D 7632816
9. Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) World Health Organization. Classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon
10. JW Vardiman NL Harris RD Brunning 2002 The World Health Organization (WHO) classification of the myeloid neoplasms Blood 100 2292 2302 10.1182/blood-2002-04-1199 1:CAS:528:DC%2BD38XnvVGisrY%3D 12239137
11. J Boultwood S Lewis JS Wainscoat 1994 The 5q-syndrome Blood 84 3253 3260 1:CAS:528:DyaK2cXmvFyjt7Y%3D 7949083
12. S Rosati R Mick F Xu E Stonys MM LeBeau R Larson JW Vardiman 1996 Refractory cytopenia with multilineage dysplasia: further characterization of an 'Unclassifiable' myelodysplastic syndrome Leukemia 10 20 26 1:STN:280:DyaK287ksFajtw%3D%3D 8558932
13. A Matsuda I Jinnai F Yagasaki S Kusumoto M Minamihisamatsu S Honda, et al. 1998 Refractory anemia with severe dysplasia: clinical significance of morphological features in refractory anemia Leukemia 12 482 485 10.1038/sj.leu.2400966 1:STN:280:DyaK1c3hs1KrsA%3D%3D 9557604 (Pubitemid 28197570)
14. A Orazi U Germing 2008 The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features Leukemia 22 1308 1319 10.1038/leu.2008.119 1:STN:280:DC%2BD1cvltFCmuw%3D%3D 18480833
15. L Malcovati M Cazzola 2008 Myelodysplastic/myeloproliferative disorders Haematologica 93 4 6 10.3324/haematol.11374 18166777 (Pubitemid 351156143)
16. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO Classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon
17. JW Vardiman J Thiele DA Arber RD Brunning MJ Borowitz A Porwit, et al. 2009 The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Blood 114 937 951 10.1182/blood-2009-03-209262 1:CAS:528:DC%2BD1MXps1eit70%3D 19357394
18. S Knipp C Strupp N Gattermann B Hildebrandt M Schapira A Giagounidis, et al. 2008 Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome Leuk Res 32 33 37 10.1016/j.leukres.2007.02.021 17412418 (Pubitemid 350100831)
19. A Matsuda U Germing I Jinnai M Iwanaga M Misumi A Kuendgen, et al. 2007 Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification Leukemia 21 678 686 1:STN:280:DC%2BD2s7ntVGjtg%3D%3D 17268513
20. E Verburgh R Achten VJ Louw C Brusselmans M Delforge M Boogaerts, et al. 2007 A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification Leukemia 21 668 677 1:STN:280: DC%2BD2s7ntV2juw%3D%3D 17301818
21. D Liu Z Chen Y Xue D Lu Y Zhou J Gong, et al. 2009 The significance of bone marrow cell morphology and its correlation with cytogenetic features in the diagnosis of MDS-RA patients Leuk Res 33 1029 1038 10.1016/j.leukres.2009.02. 011 19411106
22. R Buckstein K Jang J Friedlich L Zhang M Reis A Chesney RA Wells 2009 Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows Leuk Res 33 1313 1318 10.1016/j.leukres.2009.02.010 19282029
23. JE Goasguen JM Bennett 1992 Classification and morphologic features of the myelodysplastic syndromes Semin Oncol 19 4 13 1:STN:280:DyaK387ktFyhtQ%3D%3D 1736369
24. L Vila C Charrin E Archimbaud D Treille-Ritouet J Fraisse P Felman, et al. 1990 Correlations between cytogenetics and morphology in myelodysplastic syndromes Blut 60 223 227 10.1007/BF01728788 1:STN:280:DyaK3c3kvVGrtQ%3D%3D 2337681 (Pubitemid 20164731)
25. HJ Olney MM LeBeau 2001 The cytogenetics of myelodysplastic syndromes Best Pract Res Clin Hematol 14 479 495 10.1053/beha.2001.0151 1:CAS:528:DC%2BD38Xhs1Onsw%3D%3D (Pubitemid 33019747)
26. U Bacher T Haferlach W Kem T Weiss S Schnittger C Haferlach 2009 The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes Cancer 115 4524 4532 10.1002/cncr.24501 19569249
27. R Hast I Nilsson S Widell A Ost 1989 Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes Leuk Res 13 173 178 10.1016/0145-2126(89)90142-2 1:STN:280:DyaL1M7otVaisw%3D%3D 2927174 (Pubitemid 19079402)
28. F Tassin W Dewé N Schaaf C Herens C Ravoet A Albert, et al. 2000 A four-parameter index of marrow dysplasia has predictive value for survival in myelodysplastic syndromes Leuk Lymphoma 36 485 496 10.3109/10428190009148396 1:STN:280:DC%2BD3c3ksV2kuw%3D%3D 10784393
29. A Matsuda I Jinnai Y Miyazaki M Tomonaga 2008 Proposals for a grading system for diagnostic accuracy of myelodysplastic syndromes Clin Leuk 2 102 106 10.3816/CLK.2008.n.012
30. A Cantù Rajnoldi S Fenu G Kerndrup ER van Wering CM Niemeyer I Baumann 2005 Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS) Ann Hematol 84 429 433 10.1007/s00277-005-1034-4 15838669 (Pubitemid 40867918)
31. R Invernizzi E Travaglino GM Della Porta L Malcovati V Matti M Cazzola 2009 A standardized morphological panel for the assessment of bone marrow dysplasia improve on the accuracy of WHO classification in myelodysplastic syndrome Haematologica 94 s4 34
32. GJ Mufti JM Bennett J Goasguen BJ Bain I Baumann R Brunning, et al. 2008 Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts Haematologica 93 1712 1717 10.3324/haematol.13405 18838480
33. G Lambertenghi-Deliliers C Annaloro A Oriani D Soligo 1992 Myelodysplastic syndrome associated with bone marrow fibrosis Leuk Lymphoma 8 51 55 10.3109/10428199209049817 1:STN:280:DyaK3s7ltlektA%3D%3D 1493471
34. N Tuzuner C Cox JM Rowe D Watrous JM Bennett 1995 Hypocellular myelodysplastic syndromes (MDS): new proposals Br J Haematol 91 612 617 10.1111/j.1365-2141.1995.tb05356.x 1:STN:280:DyaK28%2FkvV2jsw%3D%3D 8555063
35. JM Bennett A Orazi 2009 Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach Haematologica 94 264 268 10.3324/haematol.13755 19144661
36. MG Della Porta L Malcovati E Boveri E Travaglino D Pietra C Pascutto, et al. 2009 Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes J Clin Oncol 27 754 762 10.1200/JCO.2008.18.2246 19103730
37. P Valent HP Horny JM Bennett C Fonatsch U Germing P Greenberg, et al. 2007 Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference Leuk Res 31 727 736 10.1016/j.leukres.2006.11.009 17257673 (Pubitemid 46855901)
38. A Mazzone C Porta G Fossati D Gritti I Mazzucchelli G Ricevuti 1996 Granulocyte dysplasia and dysfunction, and CD11/CD18 defects in myelodysplastic syndromes Leuk Lymphoma 23 267 275 10.3109/10428199609054829 1:STN:280:DyaK2s7ot12lug%3D%3D 9031107
39. L Malcovati MG Della Porta M Lunghi C Pascutto L Vanelli E Travaglino, et al. 2005 Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome Leukemia 19 776 783 10.1038/sj.leu. 2403680 1:CAS:528:DC%2BD2MXjsFOkt7o%3D 15789068 (Pubitemid 40663097)
40. MG Della Porta L Malcovati R Invernizzi E Travaglino C Pascutto M Maffioli, et al. 2006 Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome Leukemia 20 549 555 10.1038/sj.leu. 2404142 1:STN:280:DC%2BD287msFOjsQ%3D%3D 16498394
41. MR Loken AA van de Loosdrecht K Ogata A Orfao DA Wells 2008 Flow cytometry in myelodysplastic syndromes: report from a working conference Leuk Res 32 5 17 10.1016/j.leukres.2007.04.020 17576013 (Pubitemid 350100844)
42. K Ogata MG Della Porta L Malcovati C Picone N Yokose A Matsuda, et al. 2009 Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study Haematologica 94 1066 1074 10.3324/haematol.2009.008532 19546439
43. AA van de Loosdrecht C Alhan MC Béné MG Della Porta AM Dräger J Feuillard, et al. 2009 Standardization of flow cytometry in myelodysplastic syndromes: report from the first European Leukemia Networking conference on flow cytometry in myelodysplastic syndromes Haematologica 94 1124 1134 10.3324/haematol.2009.005801 19546437
44. GJ Mufti JR Stevens DG Oscier TJ Hamblin D Machin 1985 Myelodysplastic syndromes: a scoring system with prognostic significance Br J Haematol 59 425 433 10.1111/j.1365-2141.1985.tb07329.x 1:STN:280:DyaL2M7it1GmsQ%3D%3D 3970861
45. GF Sanz MA Sanz T Vallespi MC del Canizo 1989 Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients Blood 74 395 408 1:STN:280:DyaL1MzitleltQ%3D%3D 2752119
46. C Aul N Gattermann A Heyll, et al. 1992 Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system Leukemia 6 52 59 1:STN:280:DyaK387jvF2gtA%3D%3D 1736014
47. P Morel M Hebbar JL Lai, et al. 1993 Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases Leukemia 7 1315 1323 1:STN:280:DyaK3szot1WjtA%3D%3D 8371581
48. P Morel C Declercq M Hebbar, et al. 1996 Prognostic factors in myelodysplastic syndromes: critical analysis of the impact of age and gender and failure to identify a very-low-risk-group using standard mortality ratio techniques Br J Haematol 94 116 119 10.1046/j.1365-2141.1996.6122056.x 1:STN:280:DyaK28zgtFagtg%3D%3D 8757518
49. P Greenberg C Cox MM LeBeau P Fenaux P Morel G Sanz, et al. 1997 International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 2079 2088 1:CAS:528:DyaK2sXhvVars70%3D 9058730
50. E Estey M Keating S Pierce, et al. 1997 Application of the international scoring system for myelodysplasia to M.D. Anderson patients Blood 90 2843 2846 1:CAS:528:DyaK2sXmtlegt7c%3D 9326255
51. GF Sanz MA Sanz PL Greenberg, et al. 1998 Prognostic factors and scoring systems in myelodysplastic syndromes Haematologica 83 358 368 1:STN:280:DyaK1c3lsFentw%3D%3D 9592987
52. M Pfeilstocker R Reisner T Nösslinger, et al. 1999 Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics Br J Haematol 106 455 463 10.1046/j.1365-2141.1999.01559.x 1:STN:280:DyaK1MzptVWqtQ%3D%3D 10460606 (Pubitemid 29450672)
53. U Germing N Gattermann C Strupp M Aivado C Aul 2000 Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients Leuk Res 24 983 992 10.1016/S0145- 2126(00)00088-6 1:STN:280:DC%2BD3M%2FltVyhug%3D%3D 11077111 (Pubitemid 30833152)
54. T Nösslinger R Reisner E Koller H Grüner H Tüchler H Nowotny, et al. 2001 Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution Blood 98 2935 2941 10.1182/blood.V98.10.2935 11698274
55. RB Howe A Porwit-MacDonald R Wanat R Tehranchi E Hellstrom-Lindberg 2004 The WHO classification of MDS does make a difference Blood 103 3265 3270 10.1182/blood-2003-06-2124 1:CAS:528:DC%2BD2cXjslKgsL0%3D 14684416 (Pubitemid 38525649)
56. F Sole E Luno C Sanzo, et al. 2005 Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes Haematologica 90 1168 1178 1:CAS:528: DC%2BD2MXhtFGrtL3N 16154839
57. U Germing C Strupp A Kuendgen, et al. 2006 Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes Haematologica 91 1596 1604 17145595
58. L Malcovati MG Porta C Pascutto R Invernizzi M Boni E Travaglino, et al. 2005 Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making J Clin Oncol 23 7594 7603 10.1200/JCO.2005.01.7038 16186598 (Pubitemid 46291823)
59. L Malcovati U Germing A Kuendgen MG Della Porta C Pascutto R Invernizzi, et al. 2007 Time dependent prognostic scoring system for predicting survival and leukemic evolution in the myelodysplastic syndromes J Clin Oncol 25 3503 3510 10.1200/JCO.2006.08.5696 17687155 (Pubitemid 47315575)
60. EP Alessandrino MG Della Porta A Bacigalupo MT Van Lint M Falda F Onida, et al. 2008 WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) Blood 112 895 902 10.1182/blood-2008-03- 143735 1:CAS:528:DC%2BD1cXpsVaisLs%3D 18497321
61. E Zipperer D Pelz K Nachtkamp A Kuendgen C Strupp N Gattermann, et al. 2009 The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome Haematologica 94 729 732 10.3324/haematol.2008.002063 19336740
62. B Deschler T de Witte R Mertelsmann, et al. 2006 Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches Haematologica 91 1513 1522 17082009
63. MG Della Porta L Malcovati 2009 Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome Haematologica 94 602 606 10.3324/haematol.2009.005702 19407314